MedTrace Logo

Pharmacokinetic Behavior of Phenolic Acids Derived From Black Tea

NCT01533857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-08-13

No results posted yet for this study

Summary

This study is set up to determine pharmacokinetics of phenolic acids after a single oral dose to healthy males.

Conditions

Interventions

DIETARY_SUPPLEMENT

hot water

Hot water and placebo capsule

DIETARY_SUPPLEMENT

Black tea and phenolic acids

Black tea extract and capsule with phenolic acids

Sponsors & Collaborators

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Yves Donazzolo, MD · Eurofins Optimed

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-02-29
Completion
2012-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01533857 on ClinicalTrials.gov